Effect of postprandial lipemia on plasma concentrations of A-FABP, RBP-4 and visfatin

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 9, 2010, Pages 662-668

  Ciardi, C ^a   Tatarczyk, T ^a   Tschoner, A ^a   Kranebitter, M ^a   Niederwanger, A ^a   Ebenbichler, C F ^a   Patsch, J R ^a   Pedrini, M T ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Adipocyte fatty acid binding protein; Adipocytokines; Insulin resistance; Postprandial lipemia; Retinol binding protein 4; Visfatin

Indexed keywords

ADIPOCYTOKINE; FABP4 PROTEIN, HUMAN; FATTY ACID; FATTY ACID BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; CROSSOVER PROCEDURE; DIET RESTRICTION; FAT INTAKE; FEMALE; FOOD; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; MALE;

ADIPOKINES; ADULT; BLOOD GLUCOSE; CHOLESTEROL, HDL; CROSS-OVER STUDIES; DIETARY FATS; FASTING; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, NONESTERIFIED; FEMALE; FOOD; HUMANS; HYPERLIPIDEMIAS; INSULIN; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RETINOL-BINDING PROTEINS, PLASMA; TRIGLYCERIDES;

EID: 78049366228     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.05.013     Document Type: Article

References (29)

1. Gaenzer H., Sturm W., Neumayr G., Kirchmair R., Ebenbichler C., Ritsch A., et al. Pronounced postprandial lipemia impairs endothelium-dependent dilation of the brachial artery in men. Cardiovasc Res 2001, 52(3):509-516.
2. Patsch J.R., Miesenbock G., Hopferwieser T., Muhlberger V., Knapp E., Dunn J.K., et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992, 12(11):1336-1345.
3. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation 1979, 60(3):473-485.
4. Pedrini M.T., Niederwanger A., Kranebitter M., Tautermann C., Ciardi C., Tatarczyk T., et al. Postprandial lipaemia induces an acute decrease of insulin sensitivity in healthy men independently of plasma NEFA levels. Diabetologia 2006, 49(7):1612-1618.
5. Pedrini M.T., Kranebitter M., Niederwanger A., Kaser S., Engl J., Debbage P., et al. Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels. Diabetologia 2005, 48(4):756-766.
6. Lopez S., Bermudez B., Pacheco Y.M., Villar J., Abia R., Muriana F.J. Distinctive postprandial modulation of beta cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids. Am J Clin Nutr 2008, 88(3):638-644.
7. Lopez L.M., Grimes D.A., Schulz K.F. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. Cochrane Database Syst Rev 2007, 2:CD006133.
8. Kang J.X., Wang J. A simplified method for analysis of polyunsaturated fatty acids. BMC Biochem 2005, 6:5.
9. Furuhashi M., Tuncman G., Gorgun C.Z., Makowski L., Atsumi G., Vaillancourt E., et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 2007, 447(7147):959-965.
10. Xu A., Wang Y., Xu J.Y., Stejskal D., Tam S., Zhang J., et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 2006, 52(3):405-413.
11. Baar R.A., Dingfelder C.S., Smith L.A., Bernlohr D.A., Wu C., Lange A.J., et al. Investigation of in vivo fatty acid metabolism in AFABP/aP2(-/-) mice. Am J Physiol Endocrinol Metab 2005, 288(1):E187-E193.
12. Smith A.J., Thompson B.R., Sanders M.A., Bernlohr D.A. Interaction of the adipocyte fatty acid-binding protein with the hormone-sensitive lipase: regulation by fatty acids and phosphorylation. J Biol Chem 2007, 282(44):32424-32432.
13. Gerstner J.R., Bremer Q.Z., Vander Heyden W.M., Lavaute T.M., Yin J.C., Landry C.F. Brain fatty acid binding protein (Fabp7) is diurnally regulated in astrocytes and hippocampal granule cell precursors in adult rodent brain. PLoS ONE 2008, 3(2):e1631.
14. Kowalska I., Straczkowski M., Adamska A., Nikolajuk A., Karczewska-Kupczewska M., Otziomek E., et al. Serum retinol binding protein 4 is related to insulin resistance and nonoxidative glucose metabolism in lean and obese women with normal glucose tolerance. J Clin Endocrinol Metab 2008, 93(7):2786-2789.
15. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436(7049):356-362.
16. Shea J., Randell E., Vasdev S., Wang P.P., Roebothan B., Sun G. Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men. Am J Clin Nutr 2007, 86(5):1310-1315.
17. Tosetti F., Ferrari N., Pfeffer U., Brigati C., Vidali G. Regulation of plasma retinol binding protein secretion in human HepG2 cells. Exp Cell Res 1992, 200(2):467-472.
18. Berndt J., Kloting N., Kralisch S., Kovacs P., Fasshauer M., Schon M.R., et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005, 54(10):2911-2916.
19. Pagano C., Pilon C., Olivieri M., Mason P., Fabris R., Serra R., et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 2006, 91(8):3165-3170.
20. Chen M.P., Chung F.M., Chang D.M., Tsai J.C., Huang H.F., Shin S.J., et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006, 91(1):295-299.
21. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307(5708):426-430.
22. Sun G., Bishop J., Khalili S., Vasdev S., Gill V., Pace D., et al. Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. Am J Clin Nutr 2007, 85(2):399-404.
23. Wauters M., Van Gaal L. Gender differences in leptin levels and physiology: a role for leptin in human reproduction. J Gend Specif Med 1999, 2(5):46-51.
24. Heptulla R., Smitten A., Teague B., Tamborlane W.V., Ma Y.Z., Caprio S. Temporal patterns of circulating leptin levels in lean and obese adolescents: relationships to insulin, growth hormone, and free fatty acids rhythmicity. J Clin Endocrinol Metab 2001, 86(1):90-96.
25. Fried S.K., Ricci M.R., Russell C.D., Laferrere B. Regulation of leptin production in humans. J Nutr 2000, 130(12):3127S-3131S.
26. Guerci B., Hadjadj S., Quilliot D., Ziegler O., Drouin P. No acute response of leptin to an oral fat load in obese patients and during circadian rhythm in healthy controls. Eur J Endocrinol 2000, 143(5):649-655.
27. Poppitt S.D., Leahy F.E., Keogh G.F., Wang Y., Mulvey T.B., Stojkovic M., et al. Effect of high-fat meals and fatty acid saturation on postprandial levels of the hormones ghrelin and leptin in healthy men. Eur J Clin Nutr 2006, 60(1):77-84.
28. Rubin D., Helwig U., Nothnagel M., Lemke N., Schreiber S., Folsch U.R., et al. Postprandial plasma adiponectin decreases after glucose and high fat meal and is independently associated with postprandial triacylglycerols but not with - 11388 promoter polymorphism. Br J Nutr 2008, 99(1):76-82.
29. Esposito K., Nappo F., Giugliano F., Di Palo C., Ciotola M., Barbieri M., et al. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 2003, 78(6):1135-1140.